Zhuhai Kerui Biotechnology: difference between revisions
Diff·revision 15 → 16·09:59, 24 Nov 2025
Difference between revision 15 and revision 16 of Zhuhai Kerui Biotechnology. 12 lines changed; the page grew by 1,173 bytes.
| Revision 15 — 09:56, 7 Nov 2025 DeletionDeb (talk) state which lines are held in regional stock 9,873 bytes +321 | Revision 16 — 09:59, 24 Nov 2025 BlindSampleBrid (talk) add the minimum order quantity for custom synthesis 11,046 bytes +1,173 | ||
|---|---|---|---|
| 76 | The PeptidePedia tally records 791 self-reported submissions to July 2026. Recurring themes are certificate detail, disclosure of the analytical method alongside the figure, and transit time.{{r|tally}} Method disclosure is the attribute most often singled out in this set, and it is the one that makes an independent comparison possible at all.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 76 | The PeptidePedia tally records 791 self-reported submissions to July 2026. Recurring themes are certificate detail, disclosure of the analytical method alongside the figure, and transit time.{{r|tally}} Method disclosure is the attribute most often singled out in this set, and it is the one that makes an independent comparison possible at all.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| 77 | 77 | ||
| + | 78 | === How this tally should be read === | |
| + | 79 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | |
| + | 80 | ||
| + | 81 | * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. | |
| + | 82 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | |
| + | 83 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | |
| + | 84 | ||
| 78 | == References == | 85 | == References == |
| 79 | {{reflist}} | 86 | {{reflist}} |
| ⋮ | ⋮ | ||
| 85 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 92 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 86 | 93 | ||
| + | 94 | == Further reading == | |
| + | 95 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 96 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 97 | ||
| 87 | == See also == | 98 | == See also == |
| 88 | * [[Certificate of analysis]] | 99 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 92 | * [[Research use only]] | 103 | * [[Research use only]] |
| 93 | * [[Peptide supply chain]] | 104 | * [[Peptide supply chain]] |
| + | 105 | * [[Blind sampling]] | |
| 94 | 106 | ||
| 95 | {{DEFAULTSORT:Zhuhai Kerui Biotechnology}} | 107 | {{DEFAULTSORT:Zhuhai Kerui Biotechnology}} |